These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35757141)

  • 1. Cardiac Manifestations of Myotonic Dystrophy in a Pediatric Cohort.
    Brunet Garcia L; Hajra A; Field E; Wacher J; Walsh H; Norrish G; Manzur A; Muntoni F; Munot P; Robb S; Quinlivan R; Scoto M; Baranello G; Sarkozy A; Starling L; Kaski JP; Cervi E
    Front Pediatr; 2022; 10():910660. PubMed ID: 35757141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac Abnormalities in Congenital and Childhood Myotonic Muscular Dystrophy Type 1.
    Sharma A; Singh S; Mishra SK
    Neuropediatrics; 2017 Feb; 48(1):42-44. PubMed ID: 27992942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twenty-four-hour ambulatory ECG monitoring relevancy in myotonic dystrophy type 1 follow-up: Prognostic value and heart rate variability evolution.
    Gamet A; Degand B; Le Gal F; Bidegain N; Delaubier A; Gilbert-Dussardier B; Christiaens L; Garcia R
    Ann Noninvasive Electrocardiol; 2019 Jan; 24(1):e12587. PubMed ID: 30101452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of arrhythmias in myotonic dystrophy: trial design of the RAMYD study.
    Dello Russo A; Mangiola F; Della Bella P; Nigro G; Melacini P; Bongiorni MG; Tondo C; Calò L; Messano L; Pace M; Pelargonio G; Casella M; Sanna T; Silvestri G; Modoni A; Zachara E; Moltrasio M; Morandi L; Nigro G; Politano L; Palladino A; Bellocci F
    J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):51-8. PubMed ID: 19708226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence of cardiac involvement in patients with myotonic dystrophy type 1: a cross-sectional study.
    Petri H; Witting N; Ersbøll MK; Sajadieh A; Dunø M; Helweg-Larsen S; Vissing J; Køber L; Bundgaard H
    Int J Cardiol; 2014 Jun; 174(1):31-6. PubMed ID: 24704412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1.
    Groh WJ; Groh MR; Saha C; Kincaid JC; Simmons Z; Ciafaloni E; Pourmand R; Otten RF; Bhakta D; Nair GV; Marashdeh MM; Zipes DP; Pascuzzi RM
    N Engl J Med; 2008 Jun; 358(25):2688-97. PubMed ID: 18565861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of atrio-ventricular conduction disease, long-term outcomes in patients with myotonic dystrophy types I and II.
    Ha AH; Tarnopolsky MA; Bergstra TG; Nair GM; Al-Qubbany A; Healey JS
    Pacing Clin Electrophysiol; 2012 Oct; 35(10):1262-9. PubMed ID: 22385162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Mutation Size and Cardiac Involvement in Myotonic Dystrophy Type 1: An Analysis of the DM1-Heart Registry.
    Chong-Nguyen C; Wahbi K; Algalarrondo V; Bécane HM; Radvanyi-Hoffman H; Arnaud P; Furling D; Lazarus A; Bassez G; Béhin A; Fayssoil A; Laforêt P; Stojkovic T; Eymard B; Duboc D
    Circ Cardiovasc Genet; 2017 Jun; 10(3):. PubMed ID: 28611030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history of cardiac involvement in myotonic dystrophy type 1 - Emphasis on the need for lifelong follow-up.
    Petri H; Mohammad BJY; Kristensen AT; Thune JJ; Vissing J; Køber L; Witting N; Bundgaard H; Christensen AH
    Int J Cardiol; 2024 Jul; 406():132070. PubMed ID: 38643802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of 24 h Holter monitoring in patients with myotonic dystrophy type 1.
    Joosten IBT; Janssen CEW; Horlings CGC; den Uijl D; Evertz R; van Engelen BGM; Faber CG; Vernooy K
    Europace; 2023 Feb; 25(1):156-163. PubMed ID: 35851806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DM1 Patients with Small CTG Expansions are also at Risk of Severe Conduction Abnormalities.
    Denicourt M; Pham MT; Mathieu J; Breton R
    J Neuromuscul Dis; 2015; 2(1):99-105. PubMed ID: 28198705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myotonic dystrophy type 1: clinical manifestations in children and adolescents.
    Ho G; Carey KA; Cardamone M; Farrar MA
    Arch Dis Child; 2019 Jan; 104(1):48-52. PubMed ID: 29871899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Normal Electrocardiogram Does Not Exclude Infra-Hisian Conduction Disease in Patients With Myotonic Dystrophy Type 1.
    Creta A; Providência R; Gossios T; Elliott PM; Turner C; Savvatis K; Segal OR
    JACC Clin Electrophysiol; 2021 Aug; 7(8):1038-1048. PubMed ID: 33812832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interatrial block to predict atrial fibrillation in myotonic dystrophy type 1.
    Russo V; Papa AA; Rago A; Ciardiello C; Marano M; Proietti R; Politano L; Nigro G
    Neuromuscul Disord; 2018 Apr; 28(4):327-333. PubMed ID: 29567351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Left Ventricular Systolic Dysfunction in Myotonic Dystrophy Type 1: A Systematic Review.
    Russo V; Sperlongano S; Gallinoro E; Rago A; Papa AA; Golino P; Politano L; Nazarian S; Nigro G
    J Card Fail; 2020 Oct; 26(10):849-856. PubMed ID: 31415861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac involvement in myotonic muscular dystrophy.
    Moorman JR; Coleman RE; Packer DL; Kisslo JA; Bell J; Hettleman BD; Stajich J; Roses AD
    Medicine (Baltimore); 1985 Nov; 64(6):371-87. PubMed ID: 4058303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CpG Methylation, a Parent-of-Origin Effect for Maternal-Biased Transmission of Congenital Myotonic Dystrophy.
    Barbé L; Lanni S; López-Castel A; Franck S; Spits C; Keymolen K; Seneca S; Tomé S; Miron I; Letourneau J; Liang M; Choufani S; Weksberg R; Wilson MD; Sedlacek Z; Gagnon C; Musova Z; Chitayat D; Shannon P; Mathieu J; Sermon K; Pearson CE
    Am J Hum Genet; 2017 Mar; 100(3):488-505. PubMed ID: 28257691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased temporal dispersion of myocardial repolarization in myotonic dystrophy type 1: beyond the cardiac conduction system.
    Magrì D; Piccirillo G; Bucci E; Pignatelli G; Cauti FM; Morino S; Latino P; Santini D; Marrara F; Volpe M; Antonini G; Testa M
    Int J Cardiol; 2012 May; 156(3):259-64. PubMed ID: 21112106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrocardiographic predictors of infrahissian conduction disturbances in myotonic dystrophy type 1.
    Joosten IBT; van Lohuizen R; den Uijl DW; Evertz R; de Greef BTA; van Engelen BGM; Faber CG; Vernooy K
    Europace; 2021 Feb; 23(2):298-304. PubMed ID: 33150426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical predictors of conduction disease progression in type I myotonic muscular dystrophy.
    Nazarian S; Wagner KR; Caffo BS; Tomaselli GF
    Pacing Clin Electrophysiol; 2011 Feb; 34(2):171-6. PubMed ID: 20946286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.